Buying or selling a pharmacy is never just about agreeing on a price. One of the first and most important decisions in the process is how the deal will be structured, either as an asset purchase or a share purchase. While both approaches ultimately transfer ownership, they work in very different ways and carry distinct advantages and drawbacks for buyers and sellers. Understanding these differences is essential before entering negotiations, since the chosen structure can affect tax, liability, and how smoothly the handover takes place.
What Is an Asset Purchase?
In an asset purchase, the buyer acquires the specific elements of the pharmacy business rather than the company itself. This usually includes the NHS contract, goodwill, fixtures, fittings, equipment, stock on hand, and either the lease or freehold of the premises. The buyer can choose which assets to take on and leave behind anything they do not want, such as certain liabilities or unrelated assets.
For buyers, this structure provides a cleaner break from the seller’s history. Old debts, legal issues, or tax obligations linked to the company do not automatically transfer, which reduces risk. The trade-off is that the process often involves more administrative work. Supplier contracts, staff agreements, and property leases may need to be renegotiated, and that can add time and complexity.
For sellers, an asset sale can offer flexibility, since they might keep other parts of the business or dispose of assets separately. The downside is that the sale can sometimes be less tax-efficient, especially if the pharmacy is run through a limited company, where both corporation tax and personal tax may apply when extracting the proceeds.
What Is a Share Purchase?
In a share purchase, the buyer acquires the company itself rather than just its assets. The legal entity remains the same, which means all contracts, employees, and supplier relationships continue as they are. From the outside, very little appears to have changed; the pharmacy keeps trading under the same name and agreements, but the ownership of the company’s shares has passed to the buyer.
This approach can make the transition smoother. The NHS contract, property lease, and staff contracts stay in place without the need for re-signing or renegotiation. For a buyer, this can save time and reduce disruption to the day-to-day running of the pharmacy. However, it also means taking on the company’s history. Any existing debts, tax liabilities, or compliance issues automatically become the buyer’s responsibility, which is why thorough due diligence is critical.
For sellers, a share purchase can be attractive because it usually provides a clean exit. Once the shares are sold, the company and its obligations transfer entirely to the new owner. There may also be tax advantages, especially where reliefs such as Business Asset Disposal Relief (formerly Entrepreneurs’ Relief) apply. The challenge is that buyers are often cautious about hidden liabilities and may negotiate harder on price or require warranties and indemnities to protect themselves.
Which Structure Is Best?
Choosing between an asset purchase and a share purchase depends on the specific goals of both the buyer and the seller, and no two pharmacy transactions are the same.
From the buyer’s perspective, asset purchases tend to be more appealing because they provide a layer of protection against historical risks. If the pharmacy company has unresolved tax issues, pending litigation, or regulatory breaches, these are not automatically carried over in an asset sale. Buyers also gain flexibility in deciding which assets to acquire, whether that is the NHS contract, fixtures and fittings, or the property itself. The trade-off is that this approach can be slower and more complex because contracts with landlords, suppliers, and employees may need to be transferred or renegotiated.
From the seller’s perspective, share purchases often provide the cleanest exit. Once the shares are sold, the company and all of its assets and liabilities transfer to the buyer. Sellers are usually drawn to this structure because it can offer tax advantages, particularly if reliefs such as Business Asset Disposal Relief are applicable. It can also make the handover quicker, since there is no need to separate and reassign every individual contract. The downside is that buyers are aware of the extra risk they are taking on and may push for price reductions, warranties, or indemnities to protect themselves.
Other factors to weigh up include:
- Tax treatment: The difference in how each deal is taxed can be significant for both sides.
- Employee transfer rules: In the UK, TUPE regulations apply in both structures, but the mechanics can vary slightly.
- Regulatory approvals: The NHS and GPhC requirements may be easier to navigate under one structure, depending on the circumstances.
- Financing: Some lenders may prefer one structure over another because of the way security is taken over assets or shares.
Because every transaction has its own mix of financial, operational, and regulatory considerations, the “best” structure is rarely the same from one sale to the next. It often comes down to what each party is prepared to compromise on during negotiations. This is why engaging experienced legal and financial advisers is essential before committing to either route.
Tax Implications
Tax treatment is one of the biggest factors in deciding between an asset purchase and a share purchase, and it can significantly influence the outcome for both parties.
For sellers, a share purchase is often more tax-efficient. The proceeds are usually treated as a capital gain, which may qualify for Business Asset Disposal Relief (formerly Entrepreneurs’ Relief) if the criteria are met. This can reduce the capital gains tax rate to 10 per cent on qualifying gains, making a share sale financially attractive. By contrast, an asset sale through a limited company can trigger double taxation: first, corporation tax is payable on any gains made by the company, and then further tax is charged when the owner extracts the sale proceeds for personal use.
For buyers, the picture is different. Asset purchases can be more appealing because they allow certain tax advantages. Buyers may be able to claim capital allowances on assets such as fixtures and fittings, reducing taxable profits in future years. With a share purchase, the buyer inherits the company “as is,” without the ability to revalue assets for tax purposes, which can limit future tax relief.
Because the tax position is so different depending on the structure, both buyers and sellers should take early advice from an accountant or tax adviser before agreeing on terms. Getting this right at the outset can save significant sums and prevent surprises later in the process.
Due Diligence Considerations
Due diligence plays a central role in pharmacy sales, and the level of investigation required often depends on whether the deal is structured as an asset purchase or a share purchase.
In a share purchase, the buyer takes on the entire company, including its history. This means financial records, tax compliance, staff contracts, regulatory approvals, and any outstanding disputes all remain within the business.
As a result, buyers need to dig deeply into past accounts, tax returns, supplier agreements, and General Pharmaceutical Council (GPhC) inspection reports. Warranties and indemnities are usually negotiated to protect the buyer against issues that might not surface during due diligence.
With an asset purchase, the focus shifts to verifying ownership and transferability of the specific assets being sold. Buyers will want to confirm that the NHS contract can be transferred, that the premises lease is assignable, and that staff are properly transferred under TUPE regulations.
While the risks are generally lower than with a share purchase, the process can still be complex because multiple third parties may need to consent to the transfers.
Deciding between an asset purchase and a share purchase is one of the most important choices in any pharmacy sale. Both structures achieve the same end goal of transferring ownership, but they do so in very different ways, each with its own advantages and challenges. Buyers tend to prefer asset purchases for their ability to limit risk, while sellers are often drawn to share purchases for tax efficiency and a cleaner exit.
No two transactions are identical, and what works best in one situation may not suit another. Tax considerations, employee transfers, NHS approvals, and the overall risk profile all play a role in shaping the final decision. The key is to seek specialist advice early, weigh the pros and cons carefully, and approach negotiations with a clear understanding of what each structure means in practice.
At Healthcare Plus, we support pharmacy owners and buyers through every step of this process. From clarifying deal structures to handling due diligence and guiding negotiations, our team ensures that clients make informed decisions and achieve the best possible outcome. If you are considering buying or selling a pharmacy, speaking with specialists who understand the unique challenges of the sector can give you the confidence to move forward.
